FDA Approves Sanofi Drug Jevtana for Prostate... | Gather
Links shared publicly online about this topic.
- 1,082total visits
FDA Approves Sanofi Drug Jevtana for Prostate... | Gather
View full resource at notpicky.gather.com
Tags: Cancer, Prostate Cancer, Prostate, Drug, Men's Health, FDA, Sanofi-Aventis, Oncology
Most Recently Shared on June 20, 2010 at 1:41 am By:
FDA Approves Sanofi Drug Jevtana for Prostate Cancer http://bit.ly/aRRmYf
Sanofi-aventis publishes Phase III TROPIC study data in The Lancet article
news-medical.net — “Sanofi-aventis announced today that data from the Phase III TROPIC study, which was the basis for the June 2010 U.S. Food and Drug Administration (FDA) approval of Jevtana (cabazitaxel) Injection, was published in the October 2, 2010 print edition of The Lancet in an article titled "Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial.” View full resource at news-medical.net
Most Recently Shared on October 4, 2010 at 9:25 am By:
Lung Cancer News: Sanofi-aventis publishes Phase III TROPIC study data in The Lancet article: Sanofi-aventis annou... http://bit.ly/cSeKkw
FDA Approves Prostate Cancer Drug Jevtana in Eleven Weeks
fdanews.com — “Sanofi-Aventis’ prostate cancer drug Jevtana will launch this summer following an earlier-than-expected FDA approval.” View full resource at fdanews.com
Most Recently Shared on June 23, 2010 at 12:41 am By:
FDA Approves Prostate Cancer Drug Jevtana in Eleven Weeks http://bit.ly/cfQPGB
Advertisement
